JP Morgan Chase’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDOC
VC
JP Morgan Chase's TDOC Position: Q2 2026 in Review
JP Morgan Chase reduced its Teladoc Health (TDOC) stake by 10% in Q2 2026, selling an estimated $366K and leaving 484,856 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #3587.
JP Morgan Chase first reported a position in TDOC in Q3 2015 and has held it in 44 quarters since. The position peaked at $489M in Q1 2020. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.
- JP Morgan Chase held 484,856 shares of Teladoc Health worth $4.28M as of Q2 2026.
- JP Morgan Chase sold 55,071 Teladoc Health shares in Q2 2026, an estimated $366K.
- Teladoc Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3587 holding.
- JP Morgan Chase first reported a position in Teladoc Health in Q3 2015 and has held it in 44 quarters since.
- JP Morgan Chase's Teladoc Health position peaked at $489M in Q1 2020.
- 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.